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Abstract
Introduction—The World Trade Center (WTC) disaster released a huge quantity and variety of 
toxicants into the environment. To-date, studies from each of the three major cohorts of WTC-
exposed workers have suggested “greater than expected” numbers of post-9/11 cases in some 
workers. We undertook this study to estimate the incidence of post-9/11 sarcoidosis in ~13,000 
male firefighters and EMS workers enrolled in The Fire Department of the City of New York 
(FDNY) WTC Health Program; to compare FDNY incidence to rates from unexposed, 
demographically similar men in the Rochester Epidemiology Project (REP); and, to examine rates 
by level of WTC exposure.
Methods—We calculated incidence of sarcoidosis diagnosed from 9/12/2001 to 9/11/2015, and 
generated expected sex- and age-specific rates based on REP rates. Standardized incidence ratios 
(SIR) based on REP rates, and 95% confidence intervals (95% CI) were estimated. Two sensitivity 
analyses limited cases to those with intra-thoracic symptoms or biopsy confirmation.
Results—We identified 68 post-9/11 cases in the FDNY cohort. Overall, FDNY rates were 
significantly higher than expected rates (SIR= 2.8; 95% CI= 2.2, 3.6). Including only symptomatic 
cases, the SIR decreased (SIR= 2.2; 95% CI=1.5, 3.0), but remained significantly elevated. SIRs 
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ranged from 2.7 (95% CI=2.0, 3.5) in the lower WTC exposure group to 4.2 (95% CI=1.9, 8.0) in 
the most highly exposed.
Conclusions—We found excess incident post-9/11 sarcoidosis in WTC-exposed workers. 
Continued surveillance, particularly of those most highly exposed, is necessary to identify those 
with sarcoidosis and to follow them for possible adverse effects including functional impairments 
and organ damage.
Keywords
Sarcoidosis; World Trade Center; Fire Department of the City of New York; Rochester 
Epidemiology Project
INTRODUCTION
Epidemiologic evidence suggests that, in genetically susceptible individuals, inhalation of 
particulate matter may trigger a systemic inflammatory response, [1] which can ultimately 
result in granuloma formation in any organ.[2] Sarcoidosis, a condition that occurs as part of 
an exaggerated CD4+ T cell immune response to antigens, is a multisystem granulomatous 
disease that has been known to occur in response to multiple environmental/occupational 
exposures.[1, 2] The World Trade Center (WTC) disaster released a huge quantity and 
variety of toxicants into the environment, potentially affecting between 60,000 – 70,000 
rescue/recovery workers[3] and thousands of local residents. To date, two of the three major 
cohorts of WTC-exposed rescue/recovery workers have reported “greater than expected” 
numbers of post-9/11 cases of sarcoidosis[3, 4] while the third reported an elevated 
sarcoidosis risk among specific WTC-exposed workers.[5]
Although findings of more cases than expected are consistent across the three cohorts, 
excess cases do not clarify an association between WTC exposure and incident sarcoidosis 
for several reasons. First, there is no agreed-upon baseline rate of sarcoidosis in the US. 
Published incidence and prevalence rates of sarcoidosis in non-WTC-exposed populations, 
which are often used as comparison rates for WTC-exposed, are highly variable and 
population dependent, based on race/ethnicity, geography,[6, 7] socioeconomic status and 
access to healthcare.[8] The access to care issue is of particular importance in sarcoidosis as 
a substantial proportion of cases (30–50% by various estimates) are asymptomatic,[9] of 
which a significant proportion resolve spontaneously over time, leading to an unknown 
amount of undetected and unreported disease. Second, rates from different populations can 
only be meaningfully compared when cases have been collected in the same way, i.e., when 
the method of case ascertainment is similar across groups.[10] For example, populations that 
are routinely screened for employment or for other reasons using chest x–rays will 
undoubtedly detect cases of asymptomatic disease that would otherwise have remained 
undetected, resulting in higher rates from screened populations relative to rates from 
unscreened groups. For these and other reasons, U.S. prevalence estimates have ranged from 
1 to 40 per 100,000 persons, although rates as high as 330 per 100,000 persons have been 
reported.[11] Reasonable, but possibly outdated incidence data from an early study estimate 
sarcoidosis rates in systematically screened white male military personnel as 7.2 per 100,000 
person-years (1958 – 1969).[12] Recently, age-adjusted incidence for unscreened males 
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participating in the Rochester Epidemiology Project (REP) during 1946–2013 was reported 
to be 9.4 per 100,000 person-years,[13] while another study based on health care utilization 
found incidence rates of 8.1 per 100,000 in whites.[14]
The current study is designed to assess the association between WTC exposure and 
post-9/11/2001 (9/11) sarcoidosis in 13,098 WTC-exposed Fire Department of the City of 
New York (FDNY) firefighters and emergency medical service (EMS) workers. To do so, we 
first determined sarcoidosis incidence in demographically similar individuals (mostly white 
males) from the REP, which includes all residents of Olmsted County, MN, during a similar 
time period. We also assessed screening differences between the FDNY and REP 
populations by performing a sensitivity analysis which limited the analytic group to cases 
with symptoms of intra-thoracic involvement from each population. The second sensitivity 
analysis limited the analytic group to biopsy-proven cases from each population to ensure 
similar case definitions.
The primary study aims were to: 1) Estimate the incidence of sarcoidosis from 9/12/2001 to 
9/11/2015 in male, WTC-exposed FDNY rescue/recovery workers; 2) Compare sarcoidosis 
incidence in our WTC-exposed cohort to incidence rates from demographically similar 
males from Olmsted County, MN, participating in the REP; and, 3) Examine differences in 
rates of sarcoidosis by level of WTC exposure.
MATERIALS AND METHODS
DATA COLLECTION
FDNY WTC Health Program performs periodic health evaluations on all active FDNY 
members, and on WTC-exposed retired members, both firefighters and EMS personnel, 
every 12–18 months. These monitoring visits include physician examinations and, since 
2001, completion of self-administered health questionnaires that collects information about 
WTC exposure, health behaviors including smoking history and physician-diagnosed 
sarcoidosis. WTC-exposed members are routinely offered chest radiographs 
(posterioranterior and lateral views) every 2 years as part of their monitoring exam and chest 
radiographs or chest CT scans, when clinically indicated, as part of a diagnostic exam for 
those presenting with symptoms or signs of intra-thoracic involvement.
DEFINING WTC EXPOSURE INTENSITY
WTC exposure is defined from the earliest post-9/11 health questionnaire. We categorized 
exposure into the following groups: arriving on the morning of 9/11 (arrival group 1; highest 
level of exposure); arriving after noon of 9/11 (arrival group 2); arriving on 9/12/2001 
(arrival group 3); arriving between 9/13/2001 and 9/24/2001 (arrival group 4).[15] Duration 
of WTC exposure was defined as the number of months a member worked at the WTC-site 
between 9/11 and 7/25/2002 for at least one day (range 1–10).[16]
STUDY POPULATION
The source population consisted of 14,589 male WTC-exposed firefighters and EMS 
workers who provided written consent for research. The inclusion criteria for this study 
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were: (1) having arrived at the disaster site between the morning of September 11, 2001 and 
September 24, 2001; (2) not having a pre-9/11 diagnosis of sarcoidosis; (3) having a 
working telephone number; (4) having at least 18 months of service at FDNY; and, (5) 
having taken at least one post-9/11 health questionnaire. The final study population 
consisted of 13,098 participants.
DEFINING A FDNY SARCOIDOSIS POPULATION
Years before 9/11, sarcoidosis was a key interest of the FDNY health care team because of 
its possible association with firefighting.[17, 18] Post-9/11, FDNY continued to capture 
electronic medical records for physician diagnoses of sarcoidosis (ICD9 and ICD10 codes) 
and all chest imaging interpretations for the diagnosis of sarcoidosis or for findings 
consistent with sarcoidosis (e.g., bilateral hilar/mediastinal adenopathy). Self-administered 
health questionnaires completed by all FDNY firefighters and EMS workers at their 
monitoring exams also captured self-reported sarcoidosis. In 2005, the question was refined 
as follows “Since 9/11/01 has a doctor or health professional told you that you have any of 
the following problems?” The second option on the list is “Sarcoidosis”. Once captured, the 
case was reviewed to confirm the accuracy of the medical record or self-report; to identify 
whether the case was diagnosed by FDNY physicians during a medical monitoring or 
diagnostic exam; whether the case was symptomatic at diagnosis based on the presence of 
intra-thoracic symptoms, signs or abnormal chest imaging; and, whether there was biopsy 
confirmation. If diagnosed by a non-FDNY physician, pertinent medical records were 
reviewed to determine the above.
CASE CONFIRMATION
We included only confirmed post-9/11 cases of sarcoidosis. We confirmed by history and by 
review of the medical record, requiring that all cases have physician diagnoses of 
sarcoidosis. Cases with intra-thoracic involvement were verified by review of pre-and post-
hire chest radiographs, which were also used by FDNY to confirm that cases were newly 
diagnosed post-9/11. Cases with isolated granulomatous inflammations in specific organs 
(e.g., uveitis) were included after the exclusion of other granulomatous disease diagnoses. 
Confirmed cases were defined in two ways: “biopsy-confirmed cases” were supported by 
demonstration of non-caseating granulomas and the absence of any known granulomagenic 
organism or particle on a tissue biopsy, verified by medical record review conducted by 
either an FDNY pulmonologist or trained clinician. “Non-biopsy confirmed” cases were 
similarly verified by medical records, but did not include a tissue biopsy. “Symptomatic 
cases” were also defined by review of the medical records for indication of intra-thoracic 
symptoms or signs at the time of the first diagnostic presentation.
THE ROCHESTER EPIDEMIOLOGY PROJECT
The REP, established in 1966, has medical records from over 700,000 former or current 
Olmsted County, MN residents. In 2014, Olmsted County had ~111,000 adults over 18 years 
of age.[19] At that time, about 86% of Olmsted County was white compared to the FDNY 
cohort which was ~89% white during the study period. REP records include all conditions 
that come to medical attention in Olmsted County, which includes the Mayo Clinic and 
Olmsted Medical Center, their outpatient facilities, emergency rooms and inpatient 
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hospitalizations and from private practitioners, urgent care facilities, and nursing homes. 
Over 90% of Olmsted County residents are seen by medical providers in any three year 
period. [20] According to the 2015 US Census, more than 95% of Olmsted County residents 
under age 65 had health insurance.[21]
REP provided age- and sex-specific sarcoidosis incidence rates during a similar time period 
(2002–2013) as FDNY case accrual. Given their geographic distance from NYC (~1,300 
miles), it is likely that REP participants are entirely non-WTC-exposed. Occupational 
history for REP participants was not available. For all REP cases, inclusion required 
physician diagnosis supported by histopathology and/or radiologic features of intra-thoracic 
sarcoidosis, compatible clinical presentation and exclusion of other granulomatous disease. 
Isolated granulomatous disease of a specific organ (e.g., uveitis 1 REP case) was included if 
there was no better alternative diagnosis.[13] REP further designated cases as biopsy proven 
or non-biopsy proven and symptomatic or non-symptomatic at diagnosis.
STATISTICAL METHODS
Sarcoidosis incidence was calculated as number of confirmed cases per 100,000 person-
years. Person-time (denominator) accrual began on: September 12, 2001 or the FDNY hire 
date, whichever was later. Follow-up ended on the earliest of the following dates: death, end 
of the study (9/11/2015), or, for retired members, the last FDNY treatment or FDNY 
medical monitoring visit. Approximate 95% confidence intervals (CI) were calculated for 
standardized incidence ratios (SIR) using the Poisson distribution [22] and for direct 
standardized incidence rates using the modified Gamma approximation method,[23] which 
assumes a Poisson distribution. FDNY annual incidence rates were directly standardized to 
the US 2010 adult male population age 18 and over, and were compared to previously 
published REP incidence rates also standardized to the US 2010 adult male population.[13]
To compare FDNY rates with REP rates in men, the age-specific expected number of cases 
for the FDNY cohort was generated by applying the REP rates. The observed and expected 
numbers of cases were compared using 3 definitions of WTC-exposure: (1) arrival group 1 
vs. later arrival; (2) long vs. short duration of work at the WTC site (median split < 3.0 
months or ≥ 3.0 months); or, (3) by a composite measure of higher (arrival group 1 and ≥ 3.0 
months at the site) vs. lower exposure. Exposure not designated as “higher” was labeled 
“lower”. Standardized incidence ratios (SIR), which are the ratios of the observed number of 
cases in FDNY to the expected number of cases based on REP rates, were calculated 
assuming the expected rates are fixed and that the observed number of cases follows a 
Poisson distribution. An SIR>1 indicates the observed number of cases is higher than 
expected and SIR<1 indicates the observed number of cases is lower than expected. We also 
performed two sensitivity analyses. The first generated expected cases and SIRs based on 
cases with symptoms of intra-thoracic involvement from each site, and the second generated 
expected cases and SIRs based on only biopsy proven cases from each site.
All analyses were performed using the statistical software SAS (version 9.4; SAS Institute 
Inc., Cary, N.C., USA). The study was approved by the institutional review board at 
Montefiore Medical Center.
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RESULTS
From 9/12/2001 – 9/11/2015, we identified 68 confirmed cases of post-9/11 sarcoidosis, of 
whom 67 (98.5%) had evidence of intra-thoracic involvement and 1 only had evidence of 
uveitis (Table 1). The median age at diagnosis was 43.2 (IQR 38.3 – 47.2) years. As has 
been shown in other studies, cases were also more likely to report never-smoking (72% 
FDNY vs. 56% REP; p = 0.093). Ascertainment of exposure occurred well before diagnosis. 
The median time between ascertainment of arrival time to the WTC-site from the monitoring 
questionnaire and diagnosis of sarcoidosis was 5.7 years; the median time between 
ascertainment of duration of exposure and diagnosis of sarcoidosis was 3.1 years because 
duration questions were a later addition to our monitoring questionnaire.
Figure 1 graphs the number of post-9/11 cases by year of diagnosis. The highest number of 
incident diagnoses occurred during years 7–9 (i.e., 7 to 9 years after 9/11 or 2008 – 2010). 
Overall, the age-adjusted incidence of sarcoidosis was significantly higher in the FDNY 
cohort: 25.5 (95% CI=19.6, 47.2) vs. 10.2 (95% CI=7.7, 12.7) per 100,000 in the REP 
(Table 2). FDNY cases were limited to men 30 – 69 years of age whereas the age range for 
REP included both younger and older men. The median age at diagnosis of FDNY and REP 
cases was similar: 43.2 years for FDNY and 45.8 years for REP participants (p=0.17).
Figure 2 graphs the post-9/11 incidence of sarcoidosis by SIR overall (SIR=2.8; 95% 
CI=2.2, 3.6) and by various exposure characteristics. We observed 68 cases of sarcoidosis 
during the study period, which was considerably higher than the expected number (n=24.1), 
based on REP age-adjusted rates. The difference between expected and observed cases was 
greatest among persons whose composite level of WTC exposure was highest: the higher 
exposure group had 9 observed cases, which was considerably greater than the expected 
number (n=2.1; SIR=4.2; 95% CI=1.9, 8.0). In the sensitivity analysis that was restricted to 
cases with intra-thoracic involvement, we included only those who were symptomatic at the 
time of diagnosis, 53.7% of FDNY cases vs.74.2% of REP cases. Based on REP 
symptomatic rates, we expected 16.5 FDNY cases, but observed 36 cases, (SIR=2.2; 95% 
CI=1.5, 3.0). As anticipated, most likely due to FDNY screening practices, the SIR for 
asymptomatic cases was even higher, SIR= 4.4 (95% CI=3.0, 6.2) (Observed = 31; Expected 
= 7.1). In the second sensitivity analysis, considering only biopsy-proven cases (FDNY 
n=63, 92.6%), we expected 17.6 FDNY cases, but observed 63 (SIR=3.6; 95% CI=2.7, 4.6).
DISCUSSION
FDNY rescue/recovery workers experienced an increased risk of sarcoidosis starting soon 
after 9/11 which persisted, at least through 2013. Comparing demographically similar males, 
age-adjusted rates of sarcoidosis were significantly higher in the FDNY cohort: 
25.5/100,000 vs. 10.2/100,000 in the REP. The REP comparison rates we reported are 
consistent with rates from a large recent study based in Olmsted County, MN (9.4 per 
100,000 men) [13] and 2012 rates from a Midwestern population generated by analyses of 
health care use (9.5 per 100,000 adults) [14], validating our decision to use the REP as a 
reference population. By level of WTC exposure, SIRs ranged from 2.7 in the low exposure 
group to 4.2 in the most highly exposed, although the confidence intervals overlapped, likely 
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due to small numbers. Since exposure information was collected years before diagnosis, at a 
median 5.7 years for arrival time and 3.1 years for duration, it is unlikely that recall bias was 
a factor in the observed association. Accordingly, we believe that the observed dose-
response trend in post-9/11 incidence may support an association between WTC exposure 
and incident sarcoidosis.
Critics of post-9/11 sarcoidosis incidence studies in WTC-exposed responders have raised a 
number of valid methodologic issues that suggest that observed increases are partially or 
entirely due to enhanced case finding.[24, 25] To address this point, we undertook two 
sensitivity analyses. The first limited both REP and FDNY cases to persons with 
symptomatic intra-thoracic involvement at presentation, as we reasoned that these 
individuals would likely have received a sarcoidosis diagnosis regardless of screening 
practices. While the SIR was diminished, we found a two-fold risk for the FDNY cohort in 
symptomatic individuals, suggesting that the increased incidence in the FDNY population 
cannot be entirely attributed to detection bias. The second sensitivity analysis included only 
biopsy-proven FDNY and REP cases, and similarly showed excess cases in the FDNY 
cohort: SIR 3.6. This is reassuring, as it indicates that our population does, in fact, have 
sarcoidosis – a sometimes difficult to diagnose disease, and speaks to similar case 
definitions in both cohorts. While these sensitivity analyses represent our attempt to reduce 
the impact of routine surveillance, we acknowledge the likelihood that some of our cases, 
particularly asymptomatic ones, would not have been diagnosed in the community.
As sarcoidosis has long been viewed as a potential consequence of firefighting, FDNY has 
previously published two studies of sarcoidosis, one describing 25 pre-9/11 cases (1985–
1998) [17] and another describing 26 post-9/11 ones (2001–2006).[5] In the latter study, the 
incidence rate was highest in the first post-9/11 year (86/100,000), but decreased over the 
next 4 years to compare favorably with the age-adjusted rate we report: 22/100,000 vs. 
25.4/100,000 in the current study. This rate is also similar to the annual incidence of 
23.1/100,000 in white males reported by the WTC non-FDNY responder cohort.[4]
Our study has several strengths. First, our REP co-investigators provided age and sex-
specific rates from a similar time period for the generation of expected FDNY rates, 
providing excellent population-based comparison rates for WTC-exposed males. Second, 
our cohort existed prior to 9/11, minimizing the risk of recruitment bias. Third, all persons in 
our cohort had the opportunity to report sarcoidosis diagnoses on their monitoring 
questionnaires or to their FDNY physicians. Reports were screened, reviewed and validated 
by our clinicians. Fourth, we confirmed by history and chest radiographs from pre-hire, and 
post hire but pre-9/11, that all our cases were first diagnosed post-9/11. Fifth, nearly all of 
our cases were biopsy proven. Finally, information about WTC-exposures was collected 
from questionnaires completed by all cohort members regardless of symptoms and, obtained 
years prior to the date of diagnosis, arguing against recall bias.
Study limitations include that we lacked an FDNY non-WTC-exposed comparison group. 
Such a group could have better accounted for the healthy worker effect, which might have 
minimized the impact of WTC work exposures on sarcoidosis outcomes as observed using 
REP comparison rates. Nonetheless, we showed that FDNY rates were significantly higher 
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than rates in a demographically similar group with high rates of health insurance and 
physician visits. Second, using REP comparison rates, we could not distinguish between the 
possible effect of firefighting and the possible effect of WTC exposure. Third, REP case 
accrual included persons diagnosed from 2002–2013, which differed from the time of 
FDNY case accrual, which began on 9/12/2001 and ended on 9/11/2015. Thus, we do not 
have comparison rates for the entirety of the follow-up period, although there is no evidence 
that secular trends substantially affected sarcoidosis incidence in men.[13] Further, missing 
and mistimed sarcoidosis diagnoses in the two cohorts could have impacted our results. Our 
primary analyses, however, aggregated FDNY cases diagnosed from 9/12/2001 – 9/11/2015 
and Olmsted County cases diagnosed from 2002 – 2013, which was done to minimize the 
impact of mistimed diagnoses on annual incidence rates, which, for that reason, we do not 
present. Our results may not be generalizable to other occupational cohorts, as our 
population was relatively small (~13,000), exclusively male, mostly white and had above-
average physical health prior to WTC-exposure. We further acknowledge that our attempt to 
control for the effect of routine screening may not have fully neutralized its impact, 
especially as we lack specific information about the frequency of chest x-rays in the REP 
population. Lastly, we do not know from the REP about possible firefighting and WTC 
exposures, which, if present, would have increased the risk for sarcoidosis, minimizing the 
difference between Olmsted County and FDNY rates (i.e., biasing results toward the null). 
We also note that we lack information from both cohorts about non-WTC-related exposures, 
both work-related and recreational.
CONCLUSION
We found excess incident sarcoidosis in FDNY WTC-exposed rescue/recovery workers. 
Continued surveillance, particularly of those most highly exposed, is necessary to identify 
those with sarcoidosis and to follow them for possible adverse effects including functional 
impairment and evidence of organ damage.
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Research highlights
• We found 68 post-9/11 sarcoidosis cases in the FDNY WTC-exposed cohort 
(N=13,098)
• FDNY sarcoidosis incidence rates were significantly higher than expected 
(SIR=2.8)
• Significantly elevated rates were observed among workers at all WTC 
exposure levels
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Figure 1. 
Sarcoidosis Cases in FDNY study population over Time
Footnote: Years in 9/11 years (i.e., Year 1 corresponds to 9/12/2001 – 9/11/2002)
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Figure 2. 
SIRs Overall and by WTC Exposure Level
Abbreviations: SIR = Standardized Incidence Ratio; LCL = Lower Confidence Limit; UCL 
= Upper Confidence Limit; Obs = Observed; Exp = Expected; Mo = Months Reference rates 
were obtained from REP’s sarcoidosis incidence rates from 2002 – 2013.
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Table 1
Demographic and other characteristics of the FDNY study population by sarcoidosis diagnosis
Characteristics
With post-9/11
Sarcoidosis Without Sarcoidosis
N % N %
Total 68 100 13,030 100
Race
  White 62 91.2 11,626 89.2
  Nonwhite 6 8.8 1,404 10.8
Class
  Firefighter 66 97.1 11,707 89.8
EMS worker 2 2.9 1,323 10.2
Age at diagnosis – years
  Median [IQR range] 43.2 [38.3–47.2] N/A
Age at 9/11 – years
  Median [IQR range] 37.4 [33.7 – 40.1] 40 [33.8–46.0]
WTC Arrival Group
  Arrival morning of 9/11 14 20.6 2,073 15.9
  Arrival afternoon of 9/11 30 44.1 6,280 48.2
  Arrival on 9/12/2001 17 25.0 2,453 18.8
  Arrival any day between 9/13/2001 and 9/24/2001 7 10.3 2,224 17.1
WTC Work duration – months
  Median [IQR range] 4.0 [2.0– 6.5] 3.0 [1.0–5.0]
Current smoking status
  Never smoker 49 72.1 7,586 58.2
  Ever smoker 19 27.9 5,444 41.8
Biopsy-confirmed 63 92.7 N/A N/A
Intra-thoracic involvement of sarcoidosisa 67 98.5 N/A N/A
Symptomatic of intrathoracic involvement at time of diagnosisb 36 53.7 N/A N/A
aN=1 case had isolated uveitis
b
Percentage of N=67 sarcoidosis cases with intra-thoracic involvement
Abbreviations: FDNY, Fire Department of the City of New York; WTC, World Trade Center
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Table 2
Age-specific rates of sarcoidosis in males
Comparison of Sarcoidosis Incidence Rates per 100,000 between
Male FDNY and REP
FDNY REPa
Age Group No. Rate No. Rate
18 to 29 years 0 0 3 2.3
30 to 39 years 19 57.9 18 14.9
40 to 49 years 35 53.0 19 15.8
50 to 59 years 13 25.2 15 14.1
60 to 69 years 1 6.0 4 6.3
70 to 79 years 0 0 4 10.5
80 to 110 years 0 0 0 0
Age-adjusted rateb 25.5 (19.6 – 47.2) 10.2 (7.7 – 1 2.7)
a
Rates for 2002–2013
b
Rates adjusted to the 2010 US adult male population
Abbreviations: FDNY, Fire Department of the City of New York; REP, Rochester Epidemiology Project
Respir Med. Author manuscript; available in PMC 2018 November 01.
